Literature DB >> 21276845

A critical analysis of single-frequency LCR databridge impedance measurements of human skin.

Erick A White1, Mark E Orazem, Annette L Bunge.   

Abstract

Testing whether the barrier of skin samples has sufficient integrity for meaningful measurements of in-vitro chemical permeability is usually required when data are generated for regulatory purposes. Recently, skin integrity has been assessed using LCR databridge measurements, which are reported as resistances determined in either series (SER) or parallel (PAR) modes at a single frequency, typically 100 or 1000Hz. Measurements made at different combinations of mode and frequency are known to differ, although the skin literature reveals confusion over the meaning of these differences and the impact on the interpretation of integrity test results. Here, the theoretical meanings of resistance and capacitance measurements in PAR and SER mode are described and confirmed experimentally. SER-mode resistances are equal to the real part of the complex impedance; whereas, PAR-mode resistances are the inverse of the real part of the admittance. Capacitance measurements reported in SER and PAR modes are similar manipulations of the imaginary parts of the complex impedance and admittance. A large body of data from human cadaver skin is used to show that the PAR-mode resistance and SER-mode capacitance measured at 100Hz are sensitive to skin resistivity, which is the electrical measurement most closely related to skin integrity.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21276845      PMCID: PMC9397369          DOI: 10.1016/j.tiv.2011.01.013

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.685


  19 in total

1.  Non-invasive assessment of the effect of formulation excipients on stratum corneum barrier function in vivo.

Authors:  Catherine Curdy; Aarti Naik; Yogeshvar N Kalia; Ingo Alberti; Richard H Guy
Journal:  Int J Pharm       Date:  2004-03-01       Impact factor: 5.875

2.  Multi-species assessment of electrical resistance as a skin integrity marker for in vitro percutaneous absorption studies.

Authors:  D J Davies; R J Ward; J R Heylings
Journal:  Toxicol In Vitro       Date:  2004-06       Impact factor: 3.500

3.  The influence of skin structure on permeability: an intersite and interspecies comparison with hydrophilic penetrants.

Authors:  R C Scott; M A Corrigan; F Smith; H Mason
Journal:  J Invest Dermatol       Date:  1991-06       Impact factor: 8.551

4.  DC electrical properties of frozen, excised human skin.

Authors:  G B Kasting; L A Bowman
Journal:  Pharm Res       Date:  1990-02       Impact factor: 4.200

5.  Dielectric constant and resistivity of epidermal stratum corneum.

Authors:  T Yamamoto; Y Yamamoto
Journal:  Med Biol Eng       Date:  1976-09

6.  Electrical properties of the epidermal stratum corneum.

Authors:  T Yamamoto; Y Yamamoto
Journal:  Med Biol Eng       Date:  1976-03

7.  Impedance spectroscopy in human skin. A refined model.

Authors:  K Kontturi; L Murtomäki
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200

8.  Improving the sensitivity of in vitro skin penetration experiments.

Authors:  G B Kasting; T G Filloon; W R Francis; M P Meredith
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

9.  Frequency dispersions of human skin dielectrics.

Authors:  C S Poon; T T Choy
Journal:  Biophys J       Date:  1981-04       Impact factor: 4.033

10.  Rapid integrity assessment of rat and human epidermal membranes for in vitro dermal regulatory testing: correlation of electrical resistance with tritiated water permeability.

Authors:  W J Fasano; L A Manning; J W Green
Journal:  Toxicol In Vitro       Date:  2002-12       Impact factor: 3.500

View more
  1 in total

1.  Characterization of damaged skin by impedance spectroscopy: mechanical damage.

Authors:  Erick A White; Mark E Orazem; Annette L Bunge
Journal:  Pharm Res       Date:  2013-05-25       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.